EUVIMEDEUVIMED entdecken
Open Access

O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner

Jiawei Qiu, Rongrong Zhao, Caizhi Ma, Qingtong Wang, Boyan Li, Yanhua Qi, Ziwen Pan, Shulin Zhao, Shaobo Wang, Zijie Gao, Xiaofan Guo, Wei Qiu und 5 weitere

Neuro-Oncology · 15.05.2025 · 27 (4) · 900-915

DOI: 10.1093/neuonc/noae268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 13.12.2024. Verfasst von Jiawei Qiu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Key Laboratory of Brain Health and Functional Remodeling, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Adenosine, Glioblastoma, Brain Neoplasms, Cell Cycle Proteins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interactions between mesenchymal glioblastoma stem cells (MES GSCs) and myeloid-derived macrophages (MDMs) shape the tumor-immunosuppressive microenvironment (TIME), promoting the progression of glioblastoma (GBM). N6-methyladenosine (m6A) plays important roles in the tumor progression. However, the mechanism of m6A in shaping the TIME of GBM remains elusive.

Methods

Single-cell RNA sequencing and bulk RNA-seq datasets were employed to identify the critical role of WTAP in interactions between MES GBM and MDMs. The biological function of WTAP was confirmed both in vitro and in vivo. Mechanistically, mass spectrum, RNA immunoprecipitation (RIP), and co-immunoprecipitation assays were conducted.

Results

Here, we identified that m6A methyltransferase Wilms’ tumor 1-associated protein (WTAP), whose protein stability could be synergistically enhanced via OGT-mediated O-GlcNAcylation and USP7-mediated de-ubiquitination, promoted LOXL2 m6A modification to enhance its mRNA stabilization in an IGF2BP2-dependent manner, upregulating secretion of LOXL2 protein (sLOXL2). sLOXL2 then interacted with integrin α5β1 on GSCs to activate FAK-ERK signaling, inducing mesenchymal transition of GSCs in an autocrine manner. Meanwhile, sLOXL2 also activated the integrin α5β1-FAK-ERK axis in MDMs, which promoted M2-like MDM phenotypes in a paracrine pathway, thereby contributing to T-cell exhaustion to induce GBM immune escape. In translational medicine, combinations of the OGT inhibitor by targeting WTAP expression and the LOXL2 antagonist by disrupting MES GSC and MDM interactions showed favorable outcomes to the anti-PD1 immunotherapy.

Conclusions

WTAP plays critical roles in mesenchymal transition of GSCs and formation of TIME, highlighting the therapeutic potential of targeting WTAP and its downstream effectors to enhance the efficacy of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineGlioblastomaBrain NeoplasmsCell Cycle ProteinsHumansAnimalsMiceDisease ProgressionTumor MicroenvironmentCell ProliferationNeoplastic Stem CellsTumor Cells, CulturedMice, NudeGene Expression Regulation, NeoplasticRNA Splicing Factors

Stichwörter der Autor:innen

WTAPglioblastomaimmunotherapym6Atumor-immunosuppressive microenvironment

Substanzen

AdenosineN-methyladenosineWTAP protein, humanCell Cycle ProteinsRNA Splicing Factors

Autor:innen und Institutionen

  • Shandong Key Laboratory of Brain Health and Functional Remodeling, Jinan, Shandong, China.
  • Department of Neurosurgery, Qilu Hospital of Shandong University, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, Shandong, China.
  • Department of Neurology, Loma Linda University Health, Loma Linda, California, USA (Xiaofan Guo).

ORCID-Profile: Gang Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province of China

Zitieren

APA

Qiu, J., Zhao, R., Ma, C., Wang, Q., Li, B., Qi, Y., Pan, Z., Zhao, S., Wang, S., Gao, Z., Guo, X., Qiu, W., Tang, W., Guo, X., Deng, L., Xue, H., & Li, G. (2025). O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro-Oncology, 27(4), 900-915. https://doi.org/10.1093/neuonc/noae268

Vancouver

Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y, et al. O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro-Oncology. 2025;27(4):900-915. doi:10.1093/neuonc/noae268

BibTeX
@article{Qiu2025,
  author = {Qiu, Jiawei and Zhao, Rongrong and Ma, Caizhi and Wang, Qingtong and Li, Boyan and Qi, Yanhua and Pan, Ziwen and Zhao, Shulin and Wang, Shaobo and Gao, Zijie and Guo, Xiaofan and Qiu, Wei and Tang, Weijie and Guo, Xing and Deng, Lin and Xue, Hao and Li, Gang},
  title = {O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner},
  journal = {Neuro-Oncology},
  year = {2025},
  volume = {27},
  number = {4},
  pages = {900--915},
  doi = {10.1093/neuonc/noae268}
}
Kostenlos starten →